Indivior to Cut Board Size at May Shareholders' Meeting

MT Newswires03:57 ET

Indivior Announces Strategic Board Restructuring

TipRanks02:08 ET

Indivior | 10-K: FY2024 Annual Report

SEC16:36 ET · Announcements

Is Indivior PLC (INDV) the Best Small Cap Pharma Stock to Buy Now?

Yahoo FinanceMar 2 18:36 ET

Trending Stocks Today | Longeveron Surges 25% Post-Market

Moomoo NewsFeb 28 17:35 ET

Indivior Director Acquires 15,000 Shares, Signaling Confidence

TipRanksFeb 28 04:48 ET

Craig-Hallum Maintains Indivior(INDV.US) With Buy Rating

Moomoo NewsFeb 27 09:33 ET · Ratings

Craig-Hallum Keeps Their Buy Rating on Indivior (INDV)

TipRanksFeb 27 09:09 ET · Ratings

Indivior CEO Mark Crossley to Step Down, Joe Ciaffoni to Succeed

TipRanksFeb 27 05:30 ET

Indivior CEO to Step Down; Successor Named

MT NewswiresFeb 27 03:12 ET

Press Release: Indivior Announces Joseph Ciaffoni Appointed Chief Executive Officer

Dow JonesFeb 27 02:00 ET

Indivior Announces Joseph Ciaffoni Appointed Chief Executive Officer >INDV.LN

Dow JonesFeb 27 02:00 ET

Jefferies Maintains Indivior(INDV.US) With Buy Rating, Cuts Target Price to $12.35

Moomoo NewsFeb 25 07:33 ET · Ratings

Indivior PLC Sees Shift in Voting Rights With Morgan Stanley Acquisition

TipRanksFeb 25 02:11 ET

Express News | Indivior PLC Morgan Stanley - Holding(S) in Company

ReutersFeb 25 02:00 ET

Indivior Gets FDA Approval for Faster Initiation of Opioid-Dependence Treatment, More Injection Options

WSJFeb 24 02:42 ET

Express News | FDA Approves Label Changes For Indivior's SUBLOCADE, Cutting Start Time To One Hour

BenzingaFeb 24 02:19 ET

Indivior's SUBLOCADE Receives FDA Approval for Rapid OUD Treatment Protocol

TipRanksFeb 24 02:11 ET

Indivior Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Yahoo FinanceFeb 22 02:32 ET

Indivior's Earnings Call: Growth Amidst Challenges

TipRanksFeb 21 19:19 ET